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Epithelial cellsThe host innate immune response to influenza virus is a key determinant of pathogenic outcomes and
long-term protective immune responses against subsequent exposures. Here, we present a direct contrast
of the host responses in primary differentiated human nasal epithelial cell (hNEC) cultures following
infection with either a seasonal H3N2 influenza virus (WT) or the antigenically-matched live-
attenuated vaccine (LAIV) strain. Comparison of the transcriptional profiles obtained 24 and 36 h post-
infection showed that the magnitude of gene expression was greater in LAIV infected relative to that
observed in WT infected hNEC cultures. Functional enrichment analysis revealed that the antiviral and
inflammatory responses were largely driven by type III IFN induction in both WT and LAIV infected cells.
However, the enrichment of biological pathways involved in the recruitment of mononuclear leukocytes,
antigen-presenting cells, and T lymphocytes was uniquely observed in LAIV infected cells. These obser-
vations were reflective of the host innate immune responses observed in individuals acutely infected
with influenza viruses. These findings indicate that cell-intrinsic type III IFN-mediated innate immune
responses in the nasal epithelium are not only crucial for viral clearance and attenuation, but may also
play an important role in the induction of protective immune responses with live-attenuated vaccines.
 2017 Elsevier Ltd. All rights reserved.1. Introduction
Influenza A viruses (IAV) remain one of the most relevant
human pathogens with annual epidemics resulting in 250,000–
500,000 deaths worldwide [16]. Annual vaccination against influ-
enza viruses is required due to frequent antigenic drift and ineffi-
cient cross-protective immunity from prior infections orvaccination. Although vaccination remains the best approach
against infection and disease, the identification of new circulating
strains and the time for production and distribution present con-
straints on vaccine development. Additionally, other host-driven
factors can contribute to the efficacy of influenza vaccines [9].
Defining host molecular responses—and the viral and host factors
interactions that trigger and regulate them—is therefore essential
to developing effective vaccines.
Live-attenuated influenza vaccine (LAIV) strains are based on
the cold-adapted master donor virus A/Ann Arbor/6/1960
(H2N2). The 6:2 reassortant vaccine viruses contain the RNA seg-
ments encoding the hemagglutinin (HA) and neuraminidase (NA)
surface antigens derived from circulating wild type influenza virus
(WT) and the six internal RNA segments derived from the master
donor virus. LAIV has been described to have three phenotypic
changes that relate to its reduced ability to cause disease: (i) it
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strains of influenza (attenuation, or at) (ii) has restricted replica-
tion at temperatures at or above 39 C (temperature sensitivity
or ts) and (iii) is able to efficiently replicate at temperatures as
low as 25 C (cold-adaptation or ca). Although several pre-clinical
[5,6,27,28] and clinical studies [17,19,30] have demonstrated that
LAIVs are safe, efficient, and an effective means of vaccination,
the mediators and correlates of protection still remain poorly
understood.
In this study, we use a whole-genome transcriptional approach
to elucidate the early response to wild-type (WT) A/Victo-
ria/361/2011 (H3N2) influenza A virus (A/Victoria/361/2011) and
an antigenically matched LAIV strain in primary differentiated
human nasal epithelial cell (hNEC) cultures. We demonstrate that
LAIV elicits robust antiviral responses, which may also restrict viral
replication. LAIV also induces enhanced chemokine secretion and
that downstream transcriptional profiles following infection with
vaccine strains are predictive of increased leukocyte and lympho-
cyte recruitment to sites of virus replication which may contribute
to the generation of a strong adaptive immune responses. These
responses are reflective of those observed in the nasal epithelium
during acute infection of humans with IAV. Thus, primary differen-
tiated hNEC cultures can model the innate immune responses pre-
sent in influenza-infected individuals and provide insight into the
molecular mechanisms of LAIV efficacy.2. Materials and methods
2.1. Viruses
Seasonal influenza A virus A/Victoria/361/2011 (H3N2) and an
antigenically-matched live attenuated influenza vaccine virus
A/Victoria/361/2011 LAIV (LAIV; HA and NA RNA segments
from A/Victoria/361/2011, and other RNA segments from A/Ann
Arbor/6/1960) were utilized in this study. Virus seed stocks were
obtained from Medimmune and virus sequences verified using
MiSeq to obtain sequences for all virus segments. The viruses are
referred to as H3N2 WT or LAIV in the manuscript. Working stocks
were generated by infecting confluent MDCK cells at an MOI of
0.01 for 48–72 h in DMEM supplemented with 0.3% bovine serum
albumin, 2 mM GlutaMax, 100 U/ml Penicillin, 100 mg/ml Strepto-
mycin, and 4 mg/ml N-acetyl Trypsin (NAT). The supernatants were
then harvested, clarified by low speed centrifugation, and ali-
quoted for storage at 70 C.
2.2. Cell culture conditions
Madin-Darby canine kidney (MDCK) cells were cultured in Dul-
becco’s modified Eagle’s medium supplemented with 10% fetal
bovine serum (FBS), 2 mM GlutaMax, 100 U/ml Penicillin and
100 mg/ml Streptomycin and maintained in a humidified environ-
ment at 37 C with 5% CO2.
Human nasal epithelial cell (hNECs) cultures (male and female
donors) were obtained from non-diseased tissue during endo-
scopic sinus surgery for non-infection related conditions and
grown in culture at the air-liquid interface (ALI) as previously
described [25,32,33]. Female and male donors were used and the
ages were between 18 and 49 years old. Tissue processing, differ-
entiation medium, and culture conditions have been previously
described in detail [12].
2.3. Infection of primary differentiated hNECs
Differentiated hNEC cultures were infected at a multiplicity of
infection (MOI) of one (high MOI) or 0.03 (low MOI) 50% tissue cul-ture infectious dose (TCID50) per cell. All incubations were per-
formed at 32 C in a humidified environment with 5% CO2. Prior
to infection, the apical surface of the cultures was washed with
200 ll DMEM (supplemented with 0.3% BSA, 2 mM Glutamax,
100 U/ml Penicillin, and 100 mg/ml Streptomycin) and the basolat-
eral media was replaced with 500–1000 ll of fresh LHC Basal
Medium:DMEM-H. The virus inoculum was added to the apical
compartment in a volume of 100 ll and incubated for 1 h, after
which the inoculum was aspirated and the apical surface was
washed three times with 200 ll phosphate buffered saline contain-
ing calcium and magnesium (PBS+). The plates were then returned
to the incubator. Both apical washes and basolateral medium were
collected and stored at 70 C. Virus production in apical washes
was quantified by determining the 50% tissue culture infectious
dose (TCID50) using MDCK cells [24] and the Reed-Muench algo-
rithm [34].
2.4. Microarray experiments and data processing
RNA was isolated from Trizol homogenates of mock, WT or LAIV
infected cells harvested at 24hpi and 36hpi Fluorescent-labeled
probes were generated from each sample using Agilent one-color
LowInput Quick Amp Labeling Kit (Agilent Technologies). All
infected samples were confirmed to express viral M2 mRNA by
quantitative RT-PCR [13,29]. Individual cRNA samples were then
hybridized to oligonucleotide microarrays for gene expression pro-
filing using SurePrint G3 Human Gene Expression v2 Microarray
Kit (G4851A; Agilent Technologies.
The primary transcriptomic data was extracted and quantile
normalized using the ‘normalizeBetweenArrays’ method available
in the ‘limma’ package of the R statistical computing software suite
and adjusted for batch effects using the ComBat software [22]. Dif-
ferential expression (DE) of H3N2 WT and LAIV was determined by
comparing the average ratio of virus-infected replicates to time-
matched and donor-matched mock-infected samples based on a
linear model fit using the ‘limma’ package. Criteria for differential
expression were an absolute fold-change of 1.5 and an adjusted p-
value of <0.05, calculated by Benjamini-Hochberg correction [3].
2.5. Functional enrichment analysis
Functional analysis of DE genes was done using Ingenuity Path-
way Analysis (IPA, Ingenuity Systems). IPA canonical pathway
enrichment was calculated using a right-tailed Fisher’s exact test
with a threshold of significance set at p-values 0.05. Enrichment
of Diseases and Biological Functions and upstream regulators anal-
ysis were based on activation |Z-scores| > 2 and p-values < 0.05.
Virus-infected cells were compared to time- and donor-matched
mock-infected samples.
2.6. Gene expression profile correlations
Correlation analysis of influenza signatures to cytokine
response gene expression profiles derived from hNECs was per-
formed using data available from the NCBI-GEO database under
the following accession number: GSE19182. Spearman correlation
coefficients (r) and confidence intervals were calculated using the
‘psych’ package in R statistical computing software suite. Virus-
infected cells were compared to time- and donor-matched mock-
infected samples.
2.7. Chemokine and cytokine measurements
Secreted chemokines and proinflammatory cytokines were
quantified from the basolateral samples of both low and high
MOI infections using multiplex ELISAs (MesoScale Diagnostics):
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(CXCL10), MCP-1, MCP-4, MDC, MIP-1a, MIP-1b, TARC, IL-8) and
Human ProInflammatory Tissue Culture 9-Plex (GM-CSF, IFN-c,
IL-1b, IL-10, IL-12p70, IL-2, IL-6, IL-8, TNF-a), respectively, follow-
ing manufacturer instructions. Samples were diluted 1:2 for the
proinflammatory cytokine panel and 1:4 for the chemokine panel
in the provided reagent diluents and run in duplicate. Plates were
washed as described above. All incubations were performed sealed
at room temperature with shaking (3000 rpm). Before reading, 2x
read buffer was added and the plates were incubated for 5 min
(ProInflammatory 9-Plex) or read immediately (Chemokine Panel
1V-Plex) on a Meso Scale Discovery SECTOR Imager 2400. Protein
concentrations were calculated using the MesoScale Diagnostics
Discovery Workbench (version 4.0.12).
2.8. Interferon ELISAs
IFN-k and IFN-b secretion were quantified from both the apical
and basolateral compartments by singleplex enzyme-linked
immunosorbent assay (ELISA). The IFN-b ELISA (VeriKine Human
Interferon Beta ELISA Kit; Pestka Biomedical Laboratories, Inc)
was performed according to manufacturer’s instructions. IFN-k
ELISAs (DIY Human IFN Lambda 3/1/2 (IL-28B/29/28A, Pestka
Biomedical Laboratories, Inc.) were performed following manufac-
turer’s instructions with the following modifications: Costar 96-
well Half-Area Plates (Corning) were coated with 50 ll of IFN-k
capture antibody overnight at room temperature, washed, and
then blocked for at least an hour in 100 ll PBS with 1% BSA. Due
to the reduced volume of the plates, all volumes from the protocol
were halved.
For both assays, samples were diluted 1:4 in PBS with 1% BSA
and analyzed in duplicate. The sealed plates were incubated at
room temperature (with the exception of the tetramethyl-
benzidine, TMB, development). Plates were washed three times
with 150 ul of wash buffer (PBS and 0.05% Tween-20) on an Aqua-
Max 4000 plate washer and then blotted dry between sample,
detection antibody, and streptavidin-horseradish peroxidase incu-
bations. Results were read on a FilterMax F5 microplate reader at
450 nm (with a 540 nm reference for IFN-k) and protein concentra-
tions were determined using SoftMax Pro 6.4.
2.9. RNA sequencing
Total RNA was extracted from nasal swabs collected from three
individuals (2 males and 1 female) confirmed to be infected with
H3N2 viruses by PCR in the 2012–13 influenza season. The individ-
uals showed symptoms of acute respiratory infection and either
fever or cough/sore throat at time of enrollment and symptom
onset occurred no longer than 4 days before enrollment. Samples
from the time of enrollment (day 0) or three days after enrollment
(day 3) were used to assess the host responses during acute infec-
tion. Samples from day 7 post enrollment were used as baseline
values because the patients were symptom free at that time.
Libraries for RNA sequencing were constructed using TruSeq RNA
Access kit (Illumina). The libraries were clonally amplified and
sequenced on a NextSeq 500 sequencing system (Illumina). Gen-
eral quality control of the raw reads was performed using FastQC.
Ribosomal RNA reads were removed via mapping by Bowtie
(v2.1.0) [26] using an index of human, mouse, and rat rRNA
sequences. The number of read pairs following ribosomal RNA
removal in each sample varied from 20 million to 100 million read
pairs. Each sample was randomly sampled down to 20 million
reads to adjust for these differences. For each sample, about 90%
of remaining reads were mapped against the human reference gen-
ome hg19, build GRCh37, from the UCSC genome browser using
STAR (v2.4.0h1) [10]. Quantitative gene counts were produced uti-lizing the human annotation associated with the genome using the
python package HT-Seq [1]. Differential gene expression analysis
was done using edgeR [35]. Statistical significance cutoff was set
at a fold change > |2| and an adjusted p-value of 0.05.2.10. Statistical analysis
Statistical analyses for viral RNA expression and high MOI virus
titers were performed using t-tests. Data from virus replication
kinetics and protein secretion were analyzed using a Multiple
Analysis of Variance (MANOVA), with time and virus as variables
in GraphPad Prism version 5.0 (GraphPad software Inc. La Jolla,
CA); p-values of < 0.05 were considered significant. ⁄ indicates a
significant differences betweenWT and LAIV samples while # indi-
cates a difference from mock-infected cultures.2.11. Data dissemination
The hNEC microarray expression data and the nasal swab RNA-
seq expression data generated in this study are available via the
following accession identifiers on the NCBI-GEO database:
GSE83285, GSE83215 and GSE81951.3. Results
3.1. Influenza A virus replication in primary differentiated human
nasal epithelial cells
To better understand the response to WT and LAIV infection in
differentiated hNEC cultures, cells were infected with a seasonal
H3N2 isolate (A/Victoria/361/2011; WT) and the antigenically-
matched LAIV strain at a high multiplicity of infection (MOI = 1).
Infectious virus production was determined at at 24 and 36 h
post-infection (hpi). There was a 10-fold decrease in infectious
virus production at 24 hpi (Fig. 1A, left) for LAIV compared to
WT virus. At 36 hpi, there were no observable differences in infec-
tious virus production (Fig. 1B, right). No differences in viral mRNA
transcription were detected in infected hNEC cultures at either 24
hpi (Fig. 1A, left) or 36 hpi (Fig. 1B, right). These data confirm that
LAIV infection in hNEC cultures leads to reduced infectious virus
particle production but equivalent viral gene expression when
compared to WT infection which has been previously demon-
strated with older LAIV strains [11,12].3.2. The host transcriptional response to LAIV infection is more robust
than that observed with WT virus infection
Having confirmed that replication of the H3N2 LAIV strain is
attenuated in hNECs, the transcriptional responses to WT and LAIV
strains were evaluated to better understand host-driven factors
that could contribute to viral restriction. Significant changes in
gene expression (fold change > |1.5|) in virus- compared to mock-
infected cells were detected at both 24 hpi (Fig. 2A) and 36 hpi
(Fig. 2B). Multidimensional scaling was used to visualize the
expression of the 432 differentially-expressed genes (DE) across
all infections. The molecular signatures that correspond to both
WT and LAIV infection are robust, as they diverge from the tran-
scriptional profiles of mock-infected samples (Fig. 2C and D).
Importantly, gene expression across donors showed a high degree
of reproducibility across replicates as well as concordance amongst
distinct donors. Between the virus strains, consistent responses
were identified at both 24 hpi (Fig. 2C) and 36hpi (Fig. 2D), largely
due to the observation that a majority of DE genes were shared
amongst strains (Fig. 2A and B). However, LAIV infection elicited
Fig. 1. Gene expression and replication of WT H3N2 and antigenically-matched live-attenuated viruses in differentiated hNEC cultures. Differentiated human nasal epithelial
cell cultures were infected at a multiplicity of infection (MOI) of 1 and incubated at 32 C. (A) Measurement of infectious virus particle production in apical supernatant of
infected hNEC cells. (B) Expression of cell-associated viral M2mRNA expression was determined by quantitative RT-PCR. * indicates p > 0.05. Three to four infected wells were
averaged for the data points shown and each data point represents one donor with 5–7 donors were used for each time point.
Fig. 2. Global analysis of the transcriptional responses to WT and antigenically-matched LAIV in differentiated hNEC cultures. (A and B) Venn Diagrams of overlap in the
response to infection withWT and LAIV in hNEC cultures. Number of differentially expressed (DE) genes following virus infection relative to time-matched mocks. Differential
gene expression cutoff was set to fold change >1.5 and a q-value <0.05 calculated using a moderated t-test with subsequent Benjamini-Hochberg correction.
Multidimensional scaling (MDS) representation of the similarities in the differential transcriptional profiles elicited by viral infection at (C) 24 hpi (D) and 36 hpi. Each donor
is represented by a distinct shape. Biological replicates are represented as single points and unique color distinguishes infectious conditions. The quality of the representation
is provided by the Kruskal Stress value, with the low percentage of Kruskal stress suggesting a faithful 2D representation of global transcriptional differences between viral
strains. (E) Average ratio of gene expression between LAIV and WT infected cells. Heatmap represents the log2 fold expression changes of 253 genes displaying a 1.2-fold-
change of expression in LAIV- over WT-infected cells relative to donor-matched, mock-infected cells.
A. Forero et al. / Vaccine 35 (2017) 6112–6121 6115a greater number of significant DE genes, which was more pro-
nounced by 36hpi (Fig. 2B).
Host responses to viral infection are aimed at preventing viral
replication and promoting pathogen clearance. To better under-
stand the differences in the host response to infection with distinctviral strains, the subset of genes within the previously defined DE
subset that showed greater than |1.2| fold-change differences
between LAIV and WT viruses was examined further. Almost 60
percent of the DE genes (253 total) were found to be more
impacted by LAIV infection (Fig. 2E). Together, these data suggest
6116 A. Forero et al. / Vaccine 35 (2017) 6112–6121that while the host response to both circulating H3N2 viruses and
antigenically-matched LAIV strains is likely regulated by similar
molecular pathways across distinct donors, the magnitude of these
responses is enhanced in LAIV-infected cells.
3.3. LAIV infection results in enhanced type III interferon-mediated
responses relative to WT virus infection
To define the host regulatory pathways involved in attenuation
of LAIV strains, the transcription factors mediating the expression
of the 253 genes found to be more differentially expressed in LAIV
infection at both 24hpi (Fig. 3A) and 36hpi (Fig. 3B) were evalu-
ated. Overall, the transcriptional factors predicted to regulate the
LAIV signature (IRF9, RELA, RELB, STAT1, JUN) have been previously
associated with the regulation of innate antiviral responses
reviewed by [18]. Canonical pathway enrichment analysis revealed
that the most significantly enriched (Enrichment score >1.3) path-
ways are involved in pathogen recognition and interferon (IFN)
synthesis, response to IFN, and antigen presentation (Fig. 3B).WT
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dendritic and epithelial cells which express the type III IFN recep-
tor [2]. To elucidate the role of type I and III IFN in the transcrip-
tional response to infection in hNECs, the relative expression of
IFN genes following infection (Fig. 3D) was evaluated. Amongst
all the DE genes following infection, significant increases were
detected in IFNb and the IFNk genes by 24 hpi. While there was
no difference in the magnitude of IFNB1 gene expression following
WT or LAIV infection, induction of IFNk genes was greater in LAIV-
infected compared to WT-infected cultures. The contrast in the
IFNk genes was most evident by 36 hpi. Concomitant with the
increased expression of these genes, was the enhanced induction
of downstream IFN-stimulated genes in LAIV-infected cells
(Fig. 3E). IFNk receptor expression was not altered in response to
infection. Together, these findings suggest that the attenuation of
LAIV infection in hNEC cultures is correlated with enhanced induc-
tion of type III IFN-dependent innate antiviral responses.
3.4. LAIV induces greater pro-inflammatory and chemotactic responses
in infected hNEC cultures
Studies into the correlates of protection of LAIV have demon-
strated that unlike the inactivated vaccines, the protective nature
of LAIV is independent of serum antibodies [30,36]. Moreover, it
has been demonstrated that the immunoprotection by LAIV vacci-
nes is associated with the induction of T cell-mediated immunity
[17,19,39]. To assess whether pro-inflammatory and chemotactic
responses induced by WT virus infection differ from those induced
by LAIV infection, the enrichment of genes known to affect biolog-
ical functions associated with the crosstalk between innate and
adaptive immune responses was examined. A unique, significant
enrichment of genes involved in the chemotaxis, activation, and
maturation of immune cells was observed, which dominated by
36hpi in LAIV-infected cultures (Fig. 4A).
Transcription factors that regulate cytokine and chemokine
expression (Fig. 3A) and pro-inflammatory canonical pathways
(Fig. 3B, blue) were amongst the subset of genes that were more
highly expressed in LAIV-infected cultures. At 36 hpi, where the
induction of chemotactic responses was most robust, there was
an increase in the secretion of the CXCR3 ligand CXCL10 in both
WT and IAV-infected hNEC cultures with a trend toward more pro-
duction in LAIV-infected cultures (Fig. 4B). This was consistent
with a significant increase in mRNA expression (Fig. 4C), of CXCR3
targeting genes CXCL9 and CXCL10. Together, these data demon-
strate that LAIV induces epithelial cell responses that may drive
the increased recruitment of lymphocytes and leukocytes to the
infected nasal epithelium.
3.5. Differentiated hNECs recapitulate the response H3N2 observed
during acute infection
Given that hNEC cultures can capture distinct transcriptional
changes following virus infection, we evaluated whether these
responses were reflective of the transcriptional changes observed
in the infected nasal epithelium of IAV-infected individuals.
Genome-wide transcriptional profiles were determined from nasal
swabs of individuals acutely infectedwithH3N2 IAV (Fig. 5A). Acute
gene responses (day 0 or 3 after influenza diagnosis)were compared
to responses at day 7 post infection (considered baseline responses).
Genes that underwent significant changes in expression (fold
change >|2|, p-value < 0.05) were identified in pathways involved
in T cell-specific, inflammatory, and antiviral functions, amongst
other immune and metabolic functions (Fig. 5B). The concordance
Fig. 5. Host transcriptional profiling in nasal swabs of patients infected with H3N2 influenza virus. Gene expression profile in nasal washes derived from H3N2-infected
donors. (A) Heatmap represents the log2-transformed gene expression at baseline (7 days post-visit) or during acute infection (time of visit or 3 days post initial visit, as
indicated) across three donors (2 male and 1 female). The average ratio of differential expression (donor-matched acute infection samples vs. baseline samples) is presented
in the first column. Columns 2–7 represent the log2-transformed gene expression at baseline (columns 2–4) or at time of initial clinical visit (columns 5–7). (B) Gene set
enrichment of canonical pathways of the 577 genes differentially expressed early during acute infection relative to baseline using IPA. Bar graph represents pathways with
significant enrichment scores (enrichment score >1.3). Bar length represents the enrichment scores, which are based on the log10 p-value as determined by Fisher’s exact
test. Bar color determines the distinct biological functions that the enriched canonical pathways are predicted to affect. (C) Correlation of hNEC and nasal epithelium-derived
transcriptional responses following IAV infection. Responses to WT and LAIV infection in hNEC cultures (x-axis) were correlated to those observed during acute infection with
H3 IAV (y-axis). Each bubble in the graph represents a DE gene in hNEC cultures. Pink color represents genes that were determined to be DE in the nasal brush, while blue
color represents genes that did not pass statistical cut-off for differential expression in the nasal brush. The Spearman correlation coefficient, r, is depicted for each contrast.
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infected hNEC cultures was then determined (Fig. 5C). Overall, the
expression changes captured in hNEC cultures following infection
with eitherWT or LAIV, showedmoderate correlationwith the gene
expression patterns observed in the nasal epithelium during acute
influenza infection. These results demonstrate that primary differ-
entiated hNEC cultures are a relevant model for evaluating the host
transcriptional response to WT and LAIV infection.
3.6. LAIV replicates less efficiently, but induces a proportionally greater
innate immune response than WT at late times post infection in a
differentiated hNEC model of a natural infection
To determine if transcriptional responses observed in high MOI
hNEC infections and from in vivo influenza infected human sam-ples were reflected in the production of IFN, chemokines and
cytokines, hNEC cultures were infected with WT and LAIV virus
at a lowMOI and virus replication as well as interferon and chemo-
kine protein production was assessed at various times post infec-
tion. As in high MOI infections, LAIV infectious virus production
is reduced in hNEC cultures relative to WT (Fig. 6A), both in kinet-
ics and peak titer. Given the reduced virus production in LAIV-
infected cells, we then assessed the induction of various innate
immune factors after WT or LAIV infection. IFNk production is sig-
nificantly elevated following infection with both viruses, in both
the apical and basolateral media relative to mock-infected cultures
(Fig. 6B and C), mirroring the predicted type III IFN production.
There was no statistically significant difference in IFNk production
between WT and LAIV-infected cultures despite reduced infectious
virus production in LAIV infections. Basolateral secretion of the
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Fig. 6. LAIV- and WT-infected hNEC cultures produce similar amounts of type III
IFNs despite different levels of infectious virus production. Apical and basolateral
media from hNEC cultures infected with a low MOI of WT or LAIV were harvested
and assessed for viral replication (A) or interferon lambda production (B and C).
During exponential replication (until 4 days post infection), LAIV replication is
significantly reduced relative to WT (p < 0.0001, MANOVA). (B) Apical and (C)
basolateral type III IFN secretion is significantly elevated relative to donor-matched
mock-infected cells but is similar between the two viral infections. Cultures from 6
donors (3 males and 3 females) were used with n = 3–4 wells per timepoint per
culture. Data represented as fold change over mock. (* = p  0.05 for WT to LAIV
comparison, # = p < 0.05 compared to mock-infected samples, MANOVA).
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Fig. 7. Chemokine secretion into the basolateral media of WT- and LAIV-infected
hNEC cultures. (A) CXCL10, (B) CCL3, and (C) CCL4 secretion is significantly greater
than in donor-matched mock infected cells for both WT and LAIV infections,
however there is no significant difference in the fold change of production induced
between the two viruses. Basolateral supernatants from hNEC cultures infected
with the indicated viruses were harvested at the indicated times and assessed for
chemokine production using the MSD chemokine analysis platform. Cultures from 6
donors (3 males and 3 females) were used with n = 3–4 wells per timepoint per
culture. Data represented as fold change over mock. (* = p  0.05 for WT to LAIV
comparison, # = p < 0.05 compared to mock-infected samples, MANOVA).
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infection in WT- and LAIV-infected hNEC cultures compared to
mock infected cultures, but there is no statistical difference in pro-
duction between WT and LAIV-infected cells (Fig. 7A–C) – again,despite reduced LAIV virus replication compared to WT virus.
CXCL10 was detected during high MOI infections (Fig. 4B) and
showed induction in both WT and LAIV infections (Fig. 7A). Secre-
tion of the macrophage inflammatory proteins CCL3 and CCL4
(Fig. 7B and C) confirm the transcriptional responses involving acti-
6120 A. Forero et al. / Vaccine 35 (2017) 6112–6121vation of leukocyte recruitment pathways (Fig. 4A). Therefore,
while the overall induction of innate immune factors is similar in
LAIV and WT infected hNEC cultures at the protein level, the
response is proportionally greater during LAIV infection given the
reduced infectious virus production seen in LAIV-infected hNEC
cultures.4. Discussion
In this study, the response of differentiated human nasal epithe-
lial cell cultures to WT and LAIV infection in vitro was examined at
the transcriptional and protein level to identify the factors associ-
ated with LAIV-mediated immune protection. The hNEC cultures
faithfully recapitulated the transcriptional responses present in
nasal swabs of humans infected with influenza, particularly in
modeling T cell-specific, inflammatory, and antiviral functions,
amongst other immune and metabolic pathways. The isolation
and differentiation of nasal epithelial cells provides a model to
study the host epithelial cell responses at the initial site of replica-
tion, allowing both transcript analysis and confirmation of protein
synthesis and secretion. This provides a targeted focus for investi-
gating host factors involved in early immune recognition and
response to WT and LAIV.
While both WT and LAIV replicate in the upper airways, only
WT is able to reach the lower lungs. Despite this, many in vitro
studies have used cells derived from the lower airways, such as
the A549 alveolar epithelial cell carcinoma line or primary cell cul-
tures derived from the trachea, bronchioles and alveoli
[4,20,21,31,37,38]. While these studies are useful for examining
pathogenesis following lung infection, they fail to faithfully recre-
ate the environment initially encountered by WT and LAIV. There
are significant differences between the cells of the upper and lower
airways, including factors such as sialic acid distribution reviewed
in [23] and innate immune response [7].
Importantly, there is also a temperature difference between the
two environments: the lower airways are maintained at 37 C but
the nasal epithelium is cooler, with an average temperature of 32
C. Influenza infections are often done at 37 C and this may impact
the induction of innate immune responses [14]. The experiments in
this study were conducted at 32 C to mimic the temperature nor-
mally experienced by nasal epithelial cells.
As previously demonstrated for older LAIV strains [11,12], the
replication of recent H3N2 LAIV strains was impaired relative to
that of WT viruses even at a permissive temperature, suggestive
of additional, epithelial-specific attenuations mediating LAIV repli-
cation efficiency. Infection with WT and LAIV resulted in a signifi-
cant induction of genes primarily involved in pathogen-
recognition, IFN synthesis, response to IFN stimulation, and inflam-
mation. The stronger induction of innate immune responses in
LAIV- compared to WT-infected hNECs may be one factor con-
tributing to LAIV attenuation in hNEC cultures.
In accordance with previous studies comparing seasonal H1N1
IAV and antigenically-matched LAIV [11], we demonstrated that
LAIV can elicit enhanced innate immune responses as compared
to a seasonal H3N2 IAV (WT) infection. Our study expands upon
the previous finding by demonstrating that heightened innate
immune responses are conserved in LAIV strains in an HA and
NA antigen-independent manner. Furthermore, the current study
provides a comprehensive view on the transcriptional landscape
in response to infection with WT and LAIV strains. Specifically,
we reveal that in hNEC cultures, the innate immune response to
influenza infection is largely driven by type I and type III IFN. How-
ever, while viral recognition results in the induction of both IFNB1
and IFNL1-3 genes, LAIV infection results in a unique enhancement
of the IFNL genes. While expression and secretion of type I andtype III IFN following viral recognition is ubiquitous amongst cell
types, the specific response to type III IFN is restricted to dendritic
and epithelial cells [2].
We demonstrate a differential induction of CXCR3 ligands,
CXCL10, CXCL9, and CXCL11, which have been shown to play an
important role in the recruitment of monocytes and lymphocytes
to the infected tissue [40]. Importantly, CXCL10 also plays an
important role in coordinating the generation of effector and mem-
ory CD8+T cells. Prior studies aimed at uncovering the correlates of
protection for LAIV have demonstrated that unlike TIV vaccination,
where serum HAI antibodies correlate well with protection from
infection, LAIV vaccination does not elicit robust neutralizing anti-
body responses [30]. Rather, LAIV is thought to induce robust cel-
lular responses and protective mucosal immune responses
[17,36,39]. This agrees with our observation of increased secretion
of the macrophage inflammatory proteins CCL3 and CCL4 following
viral infection.
Our data demonstrate that viral titer may not be solely respon-
sible for the degree of innate immune activation. The reduced
infectious virus production in LAIV-infected hNEC cultures was still
able to induce as strong of a response as WT infection and suggests
a proportionally greater immune response to LAIV. This stronger
activation of epithelial cell innate immune responses may play a
role in the induction of LAIV-induced immune responses and com-
pensate for the reduced replication of LAIV.Acknowledgements
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